A Comparative Clinical Study to evaluate Manikkadai Nool- A Siddha Diagnostic tool on Metabolic Syndrome patients attending the OPD of Siddha Clinical Research Unit, Tirupati.

The Director General0 个研究点目标入组 80 人开始时间: 待定最近更新: 2023年4月3日

试验速览

暂无简介。

•Both sex, aged between 19-60 yrs.
•Presence of three out of the five of the following criteria constituted a diagnosis of the MS in accordance with the modified NCEP ATP III recommendations as mentioned below:
•(1)WC > 102 cm in men or 88 cm in women
•(2)Fasting TG >= 1.7 mmol/l
•(3)HDL-C < 1.0 mmol/l in men or <1.3 mmol/l in women
•(4)Blood pressure >= 130/85 mmHg or hypertensive on medication (5) Fasting glucose >= 6.0 mmol/l.
•Patients with history of Metabolic Syndrome irrespective of the underlying etiology like life style disorder or any endocrine disorders.
•Healthy Volunteers to be selected based on their clinical history stating the absence of criteria mentioned under modified NCEP ATP III criteria for MetS and history of any other illness.

•Patients below 19 yrs of age and above 61yrs.
•Patients with clinical presentations or with history of infectious illness and are under treatment for the same.
•Patients with clinical history of emaciating illness like Carcinoma, H/o Chronic Kidney Disease, Liver cirrhosis, Ascites of any etiology.
•Subjects with congenital or acquired physical deformity that could interrupt measuring Manikkadai Nool measurement.

发起方

The Director General